Hickson-Bick DL et al. |
The response of neonatal rat ventricular myocytes to lipopolysaccharide-induced stress. |
2006 |
Shock |
pmid:16680021
|
Liu J et al. |
Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes. |
2009 |
Shock |
pmid:19174742
|
Guyton K et al. |
Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli. |
2003 |
Shock |
pmid:12813370
|
Kaplan JM et al. |
15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock. |
2005 |
Shock |
pmid:15988322
|
Tang J et al. |
Aspirin treatment improved mesenchymal stem cell immunomodulatory properties via the 15d-PGJ2/PPARγ/TGF-β1 pathway. |
2014 |
Stem Cells Dev. |
pmid:24730450
|
Xu X et al. |
Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation. |
2013 |
Steroids |
pmid:23707573
|
Le Mée S et al. |
7beta-Hydroxy-epiandrosterone-mediated regulation of the prostaglandin synthesis pathway in human peripheral blood monocytes. |
2008 |
Steroids |
pmid:18555503
|
Blanco M et al. |
Increased plasma levels of 15-deoxyDelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke. |
2005 |
Stroke |
pmid:15879329
|
Farrow B et al. |
Selective activation of PPARgamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator. |
2003 |
Surgery |
pmid:12947319
|
Yokoyama Y et al. |
15-Deoxy-Delta12,14-prostaglandin J2 inhibits angiotensin II-induced fibronectin expression via hepatocyte growth factor induction in human peritoneal mesothelial cells. |
2010 |
Ther Apher Dial |
pmid:20438519
|
Eligini S et al. |
15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade. |
2002 |
Thromb. Haemost. |
pmid:12353085
|
Artwohl M et al. |
Thiazolidinediones inhibit apoptosis and heat shock protein 60 expression in human vascular endothelial cells. |
2005 |
Thromb. Haemost. |
pmid:15886792
|
Ide T et al. |
Activation of nuclear receptors by prostaglandins. |
2003 |
Thromb. Res. |
pmid:14592554
|
Kumagai M et al. |
15-Deoxy-delta(12,14)-prostaglandin J2 inhibits the IL-1beta-induced expression of granulocyte-macrophage colony-stimulating factor in BEAS-2B bronchial epithelial cells. |
2004 |
Tohoku J. Exp. Med. |
pmid:14998300
|
Kang DS et al. |
15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism. |
2006 |
Toxicol. Appl. Pharmacol. |
pmid:16890972
|
Moon Y et al. |
Hypo-responsiveness of interleukin-8 production in human embryonic epithelial intestine 407 cells independent of NF-kappaB pathway: new lessons from endotoxin and ribotoxic deoxynivalenol. |
2008 |
Toxicol. Appl. Pharmacol. |
pmid:18485432
|
Lim HJ et al. |
15d-PGJ2 stimulates HO-1 expression through p38 MAP kinase and Nrf-2 pathway in rat vascular smooth muscle cells. |
2007 |
Toxicol. Appl. Pharmacol. |
pmid:17631927
|
Suk FM et al. |
15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells. |
2009 |
Toxicol. Lett. |
pmid:19429239
|
Maddox JF et al. |
15-deoxy prostaglandin J2 enhances allyl alcohol-induced toxicity in rat hepatocytes. |
2004 |
Toxicol. Sci. |
pmid:14657518
|
Schlezinger JJ et al. |
An L-tyrosine derivative and PPARgamma agonist, GW7845, activates a multifaceted caspase cascade in bone marrow B cells. |
2007 |
Toxicol. Sci. |
pmid:17400580
|